ArticleCureus2017

Sustained, Long-Term Maintenance of Remission with Single-Agent Veliparib in Recurrent Triple-Negative Breast Cancer.

Karthik Kota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.